Organogenesis Holdings Inc

ORGO NASDAQ
7.35
-0.05
-0.68%
Closed 16:19 06/18 EDT
Open
7.41
Prev Close
7.40
High
7.46
Low
7.16
Volume
20.21K
Avg Vol (3M)
47.36K
52 Week High
310.90
52 Week Low
6.28
% Turnover
0.05%
Market Cap
284.81M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Organogenesis Holdings Inc ORGO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Organogenesis Holdings Inc., formerly Avista Healthcare Public Acquisition Corp, is a regenerative medicine company. The Company focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. It also provides integrated healing solutions that substantially improve medical outcomes. The Company’s advanced wound care and surgical & sports medicine products include PuraPly, Antimicrobial (PuraPlyAM), PuraPly, Affinity, NuShield, Apligraf and Dermagraft. The Company is offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. The Company’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.
MORE >

Recently

Name
Price
%Change